Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(aminomethyl)phosphonate degradation
-
-
PWY-7805
(S)-propane-1,2-diol degradation
-
-
PWY-7013
1,2-dichloroethane degradation
-
-
12DICHLORETHDEG-PWY
1,3-beta-D-glucan biosynthesis
-
-
PWY-6773
1,3-propanediol biosynthesis (engineered)
-
-
PWY-7385
1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)
-
-
PWY-6362
2-arachidonoylglycerol biosynthesis
-
-
PWY-8052
3-hydroxy-4-methyl-anthranilate biosynthesis I
-
-
PWY-7717
3-hydroxy-4-methyl-anthranilate biosynthesis II
-
-
PWY-7765
3-hydroxyquinaldate biosynthesis
-
-
PWY-7733
3-methyl-branched fatty acid alpha-oxidation
-
-
PWY66-387
3-methylbutanol biosynthesis (engineered)
-
-
PWY-6871
4-aminobenzoate biosynthesis I
-
-
PWY-6543
4-aminobenzoate biosynthesis II
-
-
PWY-8276
4-aminobutanoate degradation V
-
-
PWY-5022
4-hydroxy-2-nonenal detoxification
-
-
PWY-7112
6-hydroxymethyl-dihydropterin diphosphate biosynthesis
-
-
6-hydroxymethyl-dihydropterin diphosphate biosynthesis III (Chlamydia)
-
-
PWY-7539
7-(3-amino-3-carboxypropyl)-wyosine biosynthesis
-
-
PWY-7286
Ac/N-end rule pathway
-
-
PWY-7800
acetaldehyde biosynthesis I
-
-
PWY-6333
acetaldehyde biosynthesis II
-
-
PWY-6330
acetylene degradation (anaerobic)
-
-
P161-PWY
adenine and adenosine salvage I
-
-
P121-PWY
adenine and adenosine salvage II
-
-
PWY-6605
adenine salvage
-
-
PWY-6610
adenosine nucleotides degradation I
-
-
PWY-6596
Aflatoxin biosynthesis
-
-
Alanine, aspartate and glutamate metabolism
-
-
alkane oxidation
-
-
PWY-2724
alpha-Linolenic acid metabolism
-
-
Amino sugar and nucleotide sugar metabolism
-
-
Aminoacyl-tRNA biosynthesis
-
-
anandamide biosynthesis I
-
-
PWY-8051
anandamide biosynthesis II
-
-
PWY-8053
anteiso-branched-chain fatty acid biosynthesis
-
-
PWY-8173
Arg/N-end rule pathway (eukaryotic)
-
-
PWY-7799
Arginine and proline metabolism
-
-
Arginine biosynthesis
-
-
aromatic biogenic amine degradation (bacteria)
-
-
PWY-7431
Ascorbate and aldarate metabolism
-
-
bacilysin biosynthesis
-
-
PWY-7626
beta-Alanine metabolism
-
-
Biosynthesis of secondary metabolites
-
-
butanol and isobutanol biosynthesis (engineered)
-
-
PWY-7396
Caprolactam degradation
-
-
Carbon fixation pathways in prokaryotes
-
-
cardenolide glucosides biosynthesis
-
-
PWY-6036
cardiolipin and phosphatidylethanolamine biosynthesis (Xanthomonas)
-
-
PWY-7509
cardiolipin biosynthesis
-
-
cardiolipin biosynthesis I
-
-
PWY-5668
cardiolipin biosynthesis II
-
-
PWY-5269
cardiolipin biosynthesis III
-
-
PWY0-1545
ceramide and sphingolipid recycling and degradation (yeast)
-
-
PWY-7119
ceramide degradation by alpha-oxidation
-
-
PWY66-388
chitin deacetylation
-
-
PWY-7118
Chloroalkane and chloroalkene degradation
-
-
cholesterol biosynthesis
-
-
cholesterol biosynthesis (diatoms)
-
-
PWY-8239
cholesterol biosynthesis (plants, early side-chain reductase)
-
-
PWY18C3-1
cholesterol biosynthesis II (via 24,25-dihydrolanosterol)
-
-
PWY66-3
choline biosynthesis III
-
-
PWY-3561
chorismate metabolism
-
-
CO2 fixation in Crenarchaeota
-
-
coenzyme A metabolism
-
-
coenzyme B biosynthesis
-
-
P241-PWY
Cysteine and methionine metabolism
-
-
cytosolic NADPH production (yeast)
-
-
PWY-7268
D-arabinitol degradation I
-
-
DARABITOLUTIL-PWY
D-arabinose degradation I
-
-
DARABCAT-PWY
D-arabinose degradation V
-
-
PWY-8334
D-myo-inositol (1,3,4)-trisphosphate biosynthesis
-
-
PWY-6364
D-myo-inositol (1,4,5)-trisphosphate degradation
-
-
PWY-6363
D-xylose degradation I
-
-
XYLCAT-PWY
D-xylose degradation II
-
-
PWY-5516
degradation of pentoses
-
-
degradation of sugar acids
-
-
degradation of sugar alcohols
-
-
diacylglycerol and triacylglycerol biosynthesis
-
-
TRIGLSYN-PWY
diphthamide biosynthesis II (eukaryotes)
-
-
PWY-7546
dolichyl-diphosphooligosaccharide biosynthesis
-
-
dopamine degradation
-
-
PWY6666-2
Drug metabolism - cytochrome P450
-
-
Entner Doudoroff pathway
-
-
ethanol degradation I
-
-
ETOH-ACETYLCOA-ANA-PWY
ethanol degradation II
-
-
PWY66-21
ethanol degradation III
-
-
PWY66-161
ethanol degradation IV
-
-
PWY66-162
ethanolamine utilization
-
-
PWY0-1477
ethene biosynthesis IV (engineered)
-
-
PWY-7126
Ether lipid metabolism
-
-
even iso-branched-chain fatty acid biosynthesis
-
-
PWY-8175
fatty acid alpha-oxidation I (plants)
-
-
PWY-2501
Fatty acid biosynthesis
-
-
fatty acid biosynthesis initiation (type I)
-
-
PWY-5966-1
Fatty acid degradation
-
-
felinine and 3-methyl-3-sulfanylbutan-1-ol biosynthesis
-
-
PWY-8001
FeMo cofactor biosynthesis
-
-
PWY-7710
flavin biosynthesis I (bacteria and plants)
-
-
RIBOSYN2-PWY
flavin biosynthesis III (fungi)
-
-
PWY-6168
geranyl acetate biosynthesis
-
-
PWY-5835
Glucosinolate biosynthesis
-
-
glutamate and glutamine metabolism
-
-
glutathione degradation (DUG pathway)
-
-
PWY-7559
Glutathione metabolism
-
-
glutathione metabolism
-
-
glutathione-mediated detoxification
-
-
glutathione-mediated detoxification I
-
-
PWY-4061
glutathione-mediated detoxification II
-
-
PWY-6842
glutathione-peroxide redox reactions
-
-
PWY-4081
glycerol-3-phosphate shuttle
-
-
PWY-6118
Glycerolipid metabolism
-
-
Glycerophospholipid metabolism
-
-
glycine betaine biosynthesis
-
-
Glycine, serine and threonine metabolism
-
-
glycogen biosynthesis III (from alpha-maltose 1-phosphate)
-
-
PWY-7900
glycogen degradation I
-
-
GLYCOCAT-PWY
Glycolysis / Gluconeogenesis
-
-
Glyoxylate and dicarboxylate metabolism
-
-
glyoxylate cycle
-
-
GLYOXYLATE-BYPASS
glyphosate degradation III
-
-
PWY-7807
heme a biosynthesis
-
-
PWY-7856
heterolactic fermentation
-
-
P122-PWY
histamine degradation
-
-
PWY-6181
homocysteine and cysteine interconversion
-
-
PWY-801
hydrogen sulfide biosynthesis II (mammalian)
-
-
PWY66-426
hypotaurine degradation
-
-
PWY-7387
indole glucosinolate activation (intact plant cell)
-
-
PWYQT-4477
Inositol phosphate metabolism
-
-
Insect hormone biosynthesis
-
-
inulin degradation
-
-
PWY-8314
isoleucine metabolism
-
-
isoprene biosynthesis II (engineered)
-
-
PWY-7391
jadomycin biosynthesis
-
-
PWY-6679
L-alanine biosynthesis I
-
-
ALANINE-VALINESYN-PWY
L-alanine degradation II (to D-lactate)
-
-
ALACAT2-PWY
L-carnitine degradation II
-
-
PWY-3641
L-cysteine biosynthesis II (tRNA-dependent)
-
-
PWY-6308
L-cysteine biosynthesis III (from L-homocysteine)
-
-
HOMOCYSDEGR-PWY
L-glutamate biosynthesis III
-
-
GLUTSYNIII-PWY
L-glutamate degradation I
-
-
GLUTAMATE-DEG1-PWY
L-glutamate degradation V (via hydroxyglutarate)
-
-
P162-PWY
L-glutamate degradation XI (reductive Stickland reaction)
-
-
PWY-8190
L-histidine biosynthesis
-
-
HISTSYN-PWY
L-isoleucine biosynthesis I (from threonine)
-
-
ILEUSYN-PWY
L-isoleucine biosynthesis II
-
-
PWY-5101
L-isoleucine biosynthesis III
-
-
PWY-5103
L-isoleucine biosynthesis IV
-
-
PWY-5104
L-isoleucine biosynthesis V
-
-
PWY-5108
L-isoleucine degradation I
-
-
ILEUDEG-PWY
L-isoleucine degradation II
-
-
PWY-5078
L-isoleucine degradation III (oxidative Stickland reaction)
-
-
PWY-8184
L-leucine biosynthesis
-
-
LEUSYN-PWY
L-leucine degradation I
-
-
LEU-DEG2-PWY
L-leucine degradation III
-
-
PWY-5076
L-leucine degradation IV (reductive Stickland reaction)
-
-
PWY-7767
L-leucine degradation V (oxidative Stickland reaction)
-
-
PWY-8185
L-lysine biosynthesis IV
-
-
LYSINE-AMINOAD-PWY
L-lysine biosynthesis V
-
-
PWY-3081
L-methionine degradation III
-
-
PWY-5082
L-phenylalanine biosynthesis I
-
-
PHESYN
L-phenylalanine biosynthesis II
-
-
PWY-3462
L-phenylalanine degradation III
-
-
PWY-5079
L-threonine degradation V
-
-
PWY66-428
L-tryptophan degradation I (via anthranilate)
-
-
TRPCAT-PWY
L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde
-
-
PWY-5651
L-tryptophan degradation V (side chain pathway)
-
-
PWY-3162
L-tryptophan degradation X (mammalian, via tryptamine)
-
-
PWY-6307
L-tryptophan degradation XI (mammalian, via kynurenine)
-
-
PWY-6309
L-tyrosine biosynthesis I
-
-
TYRSYN
L-tyrosine biosynthesis II
-
-
PWY-3461
L-tyrosine biosynthesis III
-
-
PWY-6120
L-tyrosine degradation III
-
-
PWY3O-4108
L-valine biosynthesis
-
-
VALSYN-PWY
L-valine degradation I
-
-
VALDEG-PWY
L-valine degradation II
-
-
PWY-5057
L-valine degradation III (oxidative Stickland reaction)
-
-
PWY-8183
Limonene and pinene degradation
-
-
limonene degradation IV (anaerobic)
-
-
PWY-8029
long chain fatty acid ester synthesis (engineered)
-
-
PWY-6873
metabolism of disaccharids
-
-
Metabolism of xenobiotics by cytochrome P450
-
-
methionine metabolism
-
-
methylglyoxal degradation
-
-
methylglyoxal degradation IV
-
-
PWY-5459
methylglyoxal degradation V
-
-
PWY-5458
methylwyosine biosynthesis
-
-
PWY-7285
mevalonate metabolism
-
-
mevalonate pathway I (eukaryotes and bacteria)
-
-
PWY-922
Microbial metabolism in diverse environments
-
-
mitochondrial NADPH production (yeast)
-
-
PWY-7269
mixed acid fermentation
-
-
FERMENTATION-PWY
mRNA capping I
-
-
PWY-7375
mycolate biosynthesis
-
-
PWYG-321
N-Glycan biosynthesis
-
-
NAD(P)/NADPH interconversion
-
-
PWY-5083
Naphthalene degradation
-
-
noradrenaline and adrenaline degradation
-
-
PWY-6342
odd iso-branched-chain fatty acid biosynthesis
-
-
PWY-8174
Oxidative phosphorylation
-
-
palmitate biosynthesis I (type I fatty acid synthase)
-
-
PWY-5994
palmitoyl ethanolamide biosynthesis
-
-
PWY-8055
Pantothenate and CoA biosynthesis
-
-
Pentose and glucuronate interconversions
-
-
Phenylalanine metabolism
-
-
phenylalanine metabolism
-
-
Phenylalanine, tyrosine and tryptophan biosynthesis
-
-
phenylethanol biosynthesis
-
-
PWY-5751
phenylpropanoid biosynthesis
-
-
phosphatidate biosynthesis (yeast)
-
-
PWY-7411
phosphatidate metabolism, as a signaling molecule
-
-
PWY-7039
phospholipases
-
-
LIPASYN-PWY
phospholipid remodeling (phosphatidylcholine, yeast)
-
-
PWY-7416
phosphopantothenate biosynthesis I
-
-
PANTO-PWY
phosphopantothenate biosynthesis II
-
-
PWY-3961
phytol degradation
-
-
PWY66-389
plasmalogen biosynthesis I (aerobic)
-
-
PWY-7782
polyphosphate metabolism
-
-
PWY-8138
Porphyrin and chlorophyll metabolism
-
-
Propanoate metabolism
-
-
protein N-glycosylation (Haloferax volcanii)
-
-
PWY-7661
protein N-glycosylation initial phase (eukaryotic)
-
-
MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS
protein N-glycosylation processing of mannoproteins (cis-Golgi, yeast)
-
-
PWY-8323
protein N-glycosylation processing of proteins targeted for retention in cellular organelles (cis-Golgi, yeast)
-
-
PWY-8322
protein N-glycosylation processing phase (endoplasmic reticulum, yeast)
-
-
PWY-7918
protein N-glycosylation processing phase (plants and animals)
-
-
PWY-7919
protein O-mannosylation I (yeast)
-
-
PWY-7921
protein O-mannosylation II (mammals, core M1 and core M2)
-
-
PWY-7922
protein O-mannosylation III (mammals, core M3)
-
-
PWY-7979
protein ubiquitination
-
-
PWY-7511
putrescine degradation III
-
-
PWY-0
Pyrimidine metabolism
-
-
pyrimidine metabolism
-
-
pyrimidine nucleobases salvage II
-
-
PWY-7194
pyrimidine ribonucleosides salvage III
-
-
PWY-7195
pyruvate fermentation to acetate VIII
-
-
PWY-5768
pyruvate fermentation to acetoin III
-
-
PWY3O-440
pyruvate fermentation to ethanol I
-
-
PWY-5480
pyruvate fermentation to ethanol II
-
-
PWY-5486
pyruvate fermentation to ethanol III
-
-
PWY-6587
pyruvate fermentation to isobutanol (engineered)
-
-
PWY-7111
quinoxaline-2-carboxylate biosynthesis
-
-
PWY-7734
ribitol degradation I
-
-
RIBITOLUTIL-PWY
Riboflavin metabolism
-
-
S-(6-hydroxy-4-methylhexan-4-yl)-L-cysteinylglycine biosynthesis
-
-
PWY-8301
salidroside biosynthesis
-
-
PWY-6802
salinosporamide A biosynthesis
-
-
PWY-6627
serotonin degradation
-
-
PWY-6313
solasodine glycosylation
-
-
PWY18C3-4
sphingolipid biosynthesis (yeast)
-
-
SPHINGOLIPID-SYN-PWY
Sphingolipid metabolism
-
-
sphingosine and sphingosine-1-phosphate metabolism
-
-
PWY3DJ-11470
sphingosine metabolism
-
-
Starch and sucrose metabolism
-
-
starch degradation I
-
-
PWY-842
stearate biosynthesis III (fungi)
-
-
PWY3O-355
stigma estolide biosynthesis
-
-
PWY-6453
sucrose degradation III (sucrose invertase)
-
-
PWY-621
sucrose degradation V (sucrose alpha-glucosidase)
-
-
PWY66-373
superpathway of coenzyme A biosynthesis III (mammals)
-
-
COA-PWY-1
superpathway of fermentation (Chlamydomonas reinhardtii)
-
-
PWY4LZ-257
superpathway of mycolate biosynthesis
-
-
PWY-6113
Taurine and hypotaurine metabolism
-
-
taurine biosynthesis III
-
-
PWY-8359
Terpenoid backbone biosynthesis
-
-
tetrahydrofolate metabolism
-
-
thiazole component of thiamine diphosphate biosynthesis III
-
-
PWY-6909
toxoflavin biosynthesis
-
-
PWY-7991
trehalose biosynthesis I
-
-
TRESYN-PWY
trehalose biosynthesis II
-
-
PWY-881
trehalose biosynthesis III
-
-
TREHALOSESYN-PWY
trehalose degradation II (cytosolic)
-
-
PWY0-1182
trehalose degradation VI (periplasmic)
-
-
PWY0-1466
tRNA charging
-
-
TRNA-CHARGING-PWY
tRNA methylation (yeast)
-
-
PWY-6829
tRNA splicing I
-
-
PWY-6689
tRNA splicing II
-
-
PWY-7803
Tryptophan metabolism
-
-
tryptophan metabolism
-
-
UMP biosynthesis I
-
-
PWY-5686
UMP biosynthesis II
-
-
PWY-7790
UMP biosynthesis III
-
-
PWY-7791
UTP and CTP de novo biosynthesis
-
-
PWY-7176
UTP and CTP dephosphorylation I
-
-
PWY-7185
UTP and CTP dephosphorylation II
-
-
PWY-7177
Valine, leucine and isoleucine biosynthesis
-
-
Valine, leucine and isoleucine degradation
-
-
Various types of N-glycan biosynthesis
-
-
vitamin B1 metabolism
-
-
volatile esters biosynthesis (during fruit ripening)
-
-
PWY-6801
xylitol degradation I
-
-
LARABITOLUTIL-PWY
zymosterol biosynthesis
-
-
PWY-6074
methylaspartate cycle

-
-
PWY-6728
methylaspartate cycle
-
-
octane oxidation

-
-
P221-PWY
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
-
-
brenda
-
mechanisms underlying recruitment of Ski2-like helicases to the exosome, interaction analysis, overview
-
brenda
-
-
brenda
-
-
brenda
-
-
-
brenda
-
-
brenda
-
-
brenda
-
-
-
brenda
-
-
brenda
-
-
-
brenda
-
-
brenda
-
-
brenda
-
Bmt6 is localized predominantly in the cytoplasm
brenda
-
Trm7, Trm732, and Trm734 are localized to cytoplasm
brenda
-
-
brenda
-
the intracellular localization is changed depending on the growth phase. Distributed in the cytosol until the initial logarithmic phase (12 h), then delivered to an organelle with a granule structure in the middle logarithmic phase (14 h), and finally localized at the vacuole membranes in the stationary phase (18-20 h)
brenda
-
-
brenda
-
ER, the predicted transmembrane domain localizes the N-terminus of Alg1 into the ER lumen. The N-terminal transmembrane domain including the following positively charged amino acids and an N-terminal amphiphilic-like alpha-helix domain exposed on the protein surface strictly coordinate the Alg1 orientation on the ER membrane. The N- and C-termini of Alg1 are located to luminal and cytosolic side of the ER, respectively. The conserved proline 20 residue has no effect on its membrane-spanning property. The positively charged amino acids (K35, K38, K39 and R40) downstream of the N-terminal transmembrane region are important for ER membrane attachment
brenda
-
Mpo1 mutants are localized in the endoplasmic reticulum
brenda
-
N-linked glycosylation occurs in the endoplasmic reticulum lumen by the membrane associated oligosaccharyltransferase enzyme complex
brenda
-
-
brenda
-
integral membrane protein Csg1 exhibits a membrane topology with its C-terminus in the cytosol and its mannosyltransferase domain in the lumen
brenda
-
integral membrane protein Csh1 exhibits a membrane topology with its C-terminus in the cytosol and its mannosyltransferase domain in the lumen
brenda
-
ScMnn9p enzyme is a type II membrane proteins, possessing a short cytosolic N-terminal domain followed by a transmembrane domain that is required for anchoring to the Golgi membrane
brenda
-
-
brenda
-
associated
brenda
-
ERG25 is membrane-bound
brenda
-
Gpc1p is an intergral membrane protein with eight transmembrane helices
brenda
-
membrane topology of Alg1, overview. A conserved alpha-helix domain, Alg1 Nalpha3 domain, contributes to the membrane association of Alg1 protein
brenda
-
the intracellular localization is changed depending on the growth phase. Distributed in the cytosol until the initial logarithmic phase (12 h), then delivered to an organelle with a granule structure in the middle logarithmic phase (14 h), and finally localized at the vacuole membranes in the stationary phase (18-20 h)
brenda
-
translocation of mutant W637A to the membrane is dependent on the Nem1-Spo7 protein phosphatase complex
brenda
-
transmembrane protein
brenda
-
transmembrane protein, multiple bound lipids and notable membrane distortions are observed in the FKS1 structures, suggesting active FKS1-membrane interactions
brenda
-
transmembrane protein. The architecture of the complex is a dimer of Lip1 subunits bound to the catalytic subunits Lag1 and Lac1. Each catalytic subunit forms a hydrophobic crevice connecting the cytosolic site with the intermembrane space
brenda
-
yeast Mpo1 contains two transmembrane domains and both its N- and C-terminal regions are exposed to the cytosol
brenda
-
-
brenda
-
yeast ICP55 orthologues are peripherally attached to the mitochondrial inner membrane from the matrix site
brenda
-
inner
brenda
-
the TSEN complex localizes to the mitochondrial membrane, to the outside of mitochondria
brenda
-
the yeast TSEN complex is localized to the outer side of the mitochondrial membrane
brenda
-
-
brenda
-
yeast Lon protease localizes to mitochondrial nucleoids
brenda
-
-
brenda
-
in yeast, an isoform of Icp55 has also been identified in the nucleus
brenda
-
the interaction of Ceg1 with RNA trisphophatase Cet1 essential for the nuclear localization of the Cet1-Ceg1 complex
brenda
-
-
brenda
-
peroxisomal matrix, the enzyme has a peroxisomal targeting signal type 1 (PTS1)
brenda
-
-
brenda
-
near to
brenda
-
-
-
brenda
-
Pim1p is a soluble matrix protease
-
brenda
-
-
brenda
-
Ath1 is suggested to be located in vacuoles or at the surface of the cell
brenda
additional information

-
a subpopulation of Ded1 is in close proximity to the endoplasmic reticulum, largely separate foci in close proximity. Ded1 is associated transiently with polysomes
-
brenda
additional information
-
altered localization to the mitochondria or peroxisomes prevents Gdh1, which was originally localized in the cytoplasm, from stationary phase-specific aggregation, suggesting that some cytosolic factors are involved in the process of Gdh1 aggregation
-
brenda
additional information
-
both AAA+ peroxins, Pex1 and Pex6, are stably bound to each other or have reached an equilibrium, because they are detected together as either cytosolic or membrane-bound complexes
-
brenda
additional information
-
complexed Csg1 functions in the Golgi and is then delivered to the vacuole for degradation
-
brenda
additional information
-
Hrq1 is localized to telomeres
-
brenda
additional information
-
phylogenetic analysis showed that plant PDAT can be grouped into four clades, two of which have one putative transmembrane domain (TMD) while the other two are predicted to be entirely soluble. The majority of PDAT in the database have the single-predicted TMD consisting of a small cytosolic N-terminus and a large C-terminal domain in the endoplasmic reticulum lumen. The N-terminal region is hydrophilic with arginine clusters similar to those observed in DGAT1
-
brenda
additional information
-
the spatial localization of the TSEN complex is not conserved across eukaryotes
-
brenda
additional information
-
uncomplexed Csh1 cannot exit from the endoplasmic reticulum. Complexed Csh1 functions in the Golgi and is then delivered to the vacuole for degradation
-
brenda